386 related articles for article (PubMed ID: 31724892)
21. The stimulative function of long noncoding RNA CDKN2B-AS1 in osteosarcoma by targeting the microRNA-122/CCNG1 axis.
Abula A; Saimaiti G; Maimaiti X; Wuqikun W; Abulaiti A; Ren P; Yusufu A
J Recept Signal Transduct Res; 2022 Feb; 42(1):71-79. PubMed ID: 33283575
[TBL] [Abstract][Full Text] [Related]
22. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
Ding Q; Mo F; Cai X; Zhang W; Wang J; Yang S; Liu X
J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
[TBL] [Abstract][Full Text] [Related]
23. LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion.
Deng B; Pan R; Ou X; Wang T; Wang W; Nie Y; Chen H
Biomed Res Int; 2021; 2021():5271291. PubMed ID: 33816613
[TBL] [Abstract][Full Text] [Related]
24. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101.
Yu CL; Xu NW; Jiang W; Zhang H; Ma Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697
[TBL] [Abstract][Full Text] [Related]
25. LncRNA ROR1-AS1 accelerates osteosarcoma invasion and proliferation through modulating miR-504.
Wu X; Yan L; Liu Y; Shang L
Aging (Albany NY); 2020 Dec; 13(1):219-227. PubMed ID: 33401251
[TBL] [Abstract][Full Text] [Related]
26. Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway.
Kun-Peng Z; Chun-Lin Z; Xiao-Long M
Int J Biol Sci; 2017; 13(9):1180-1191. PubMed ID: 29104509
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of ZEB2-AS1 inhibits cell proliferation, invasion and induces apoptosis in osteosarcoma by combining with EZH2.
Zhang B; Fan DB; Liu L; Qin Y; Feng DQ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6533-6539. PubMed ID: 32633340
[TBL] [Abstract][Full Text] [Related]
28. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
29. Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
Zhuang H; Cao G; Kou C; Li D
J BUON; 2019; 24(4):1441-1448. PubMed ID: 31646789
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
[TBL] [Abstract][Full Text] [Related]
31. Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis.
Lou P; Ding T; Zhan X
Cancer Biother Radiopharm; 2021 May; 36(4):371-381. PubMed ID: 32706998
[No Abstract] [Full Text] [Related]
32. Long noncoding RNA
Li S; Liu F; Pei Y; Wang W; Zheng K; Zhang X
Aging (Albany NY); 2019 Sep; 11(18):7678-7693. PubMed ID: 31525734
[TBL] [Abstract][Full Text] [Related]
33. SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression.
He JW; Li DJ; Zhou JH; Zhu YL; Yu BQ
Biochem Biophys Res Commun; 2020 Jun; 526(3):670-677. PubMed ID: 32248969
[TBL] [Abstract][Full Text] [Related]
34. Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation.
Rankin CR; Lokhandwala ZA; Huang R; Pekow J; Pothoulakis C; Padua D
Life Sci; 2019 Aug; 231():116571. PubMed ID: 31207308
[TBL] [Abstract][Full Text] [Related]
35. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
Xu C; Zhai J; Fu Y
Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
[TBL] [Abstract][Full Text] [Related]
36. LncRNA MATN1-AS1 for Prediction of Prognosis in Osteosarcoma Patients and Its Cellular Function.
Liu Y; Wang D; Ji Q; Yan J
Mol Biotechnol; 2022 Jan; 64(1):66-74. PubMed ID: 34542816
[TBL] [Abstract][Full Text] [Related]
37. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
Chen S; Li W; Guo A
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.
Yang G; Song R; Wang L; Wu X
Biomed Pharmacother; 2018 Jul; 103():1238-1245. PubMed ID: 29864904
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of TPT1-AS1 inhibits cell proliferation, cell cycle G1/S transition, and epithelial-mesenchymal transition in gastric cancer.
Tang J; Huang F; Wang H; Cheng F; Pi Y; Zhao J; Li Z
Bosn J Basic Med Sci; 2021 Feb; 21(1):39-46. PubMed ID: 32156253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
